Dr. Davidzon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford University Medical Center Nuclear Medicine
Palo Alto, CA 94305Phone+1 650-723-6855
Summary
- Dr. Guido Davidzon is specialized in Nuclear Medicine & Molecular Imaging in Stanford, CA. He is affiliated with Stanford Health Care and LPCH. He has been in practice 15 years. He speaks Spanish. He is experienced in diagnostic imaging using PET/CT and PET/MR scans in oncology, cardiovascular, and neurological disorders as well as in the use of targeted radionuclide therapy in cancer.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 2010 - 2013
- Massachusetts Institute of TechnologySM, Biomedical Informatics, 2008 - 2010
- Massachusetts General Hospital2010
- Yale-New Haven Medical CenterResidency, Surgery, 2006 - 2007
- Maimonides University Faculty of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2011 - 2025
- IL State Medical License 2013 - 2014
- American Board of Nuclear Medicine Nuclear Medicine
- Physician and Surgeon, Medical Board of California License A117782
Awards, Honors, & Recognition
- Best Essay Travel Grant Award SNM/ACNM Annual Meeting, 2012
- Young Investigator Award Symposium SNMMI, Nuclear Oncology Council, 2011
Clinical Trials
- Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT Start of enrollment: 2017 Mar 29
- [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers Start of enrollment: 2018 Apr 23
- Neuroimaging GABA Physiology in Fragile X Syndrome Start of enrollment: 2016 Nov 01
Publications & Presentations
PubMed
- Plasma Aβ/Aβis sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum.Alexandra N Trelle, Christina B Young, Hillary Vossler, Javier Ramos Benitez, Karly A Cody
Alzheimer's & Dementia. 2024-12-23 - The Challenge of External Generalisability: Insights from the Bicentric Validation of a [Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Charac...Samuele Ghezzo, Praveen Gurunath Bharathi, Heying Duan, Paola Mapelli, Philipp Sorgo
Cancers. 2024-12-07 - Elevated tau in the piriform cortex in Alzheimer's but not Parkinson's disease using PET-MR.Hossein Moein Taghavi, Mahta Karimpoor, Eric K van Staalduinen, Christina B Young, Marios Georgiadis
Alzheimer's & Dementia. 2024-11-23
Press Mentions
- Stanford University Partners with Kheiron Medical Technologies to Pioneer Use of AI in New Areas of OncologyNovember 29th, 2021
Professional Memberships
- Member
- SNMMIMember
Other Languages
- Spanish
External Links
- Linkedinhttp://www.linkedin.com/in/gdavidzon/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: